Aug 8, 2018 04:01PM
Jul 23, 2018 06:36AM
Jul 23, 2018 06:30AM
Nov 8, 2017 04:01PM
Oct 16, 2017 06:09AM
Oct 16, 2017 05:58AM
Oct 13, 2017 01:56PM Aerie Pharma (AERI) Confirms FDA Advisory Committee Voted in Favor of Rhopressa 0.02%
Oct 13, 2017 01:55PM
Oct 13, 2017 07:06AM
Oct 13, 2017 07:05AM
Oct 9, 2017 06:30AM
Oct 5, 2017 06:18AM
Oct 5, 2017 06:03AM
Oct 5, 2017 06:00AM Aerie Pharmaceuticals Announces Drug Delivery Asset Acquisition to Further Advance Its Retinal Disease Program
Oct 2, 2017 06:30AM
Sep 29, 2017 06:30AM
Sep 25, 2017 06:30AM
Sep 20, 2017 04:02PM
Sep 20, 2017 04:01PM
Sep 20, 2017 10:29AM
Sep 19, 2017 06:30AM Aerie Pharmaceuticals Announces Appointment of Tori Arens as Vice President of Drug Product Manufacturing and Eric Carlson, Ph.D. as Vice President of Research and Development
Sep 6, 2017 06:34AM
Sep 6, 2017 06:30AM
Aug 28, 2017 06:30AM
Aug 14, 2017 06:30AM
Aug 8, 2017 05:16PM
Aug 8, 2017 04:01PM
Aug 1, 2017 04:01PM Aerie Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Business Update
Jul 31, 2017 06:32AM
Jul 31, 2017 06:30AM
Jul 25, 2017 06:38AM
Jul 25, 2017 06:30AM
Jul 19, 2017 04:01PM
Jul 19, 2017 04:01PM
May 26, 2017 06:31AM Aerie Pharma (AERI) Prices $75M Common Stock Offering at $53.75/Share; $50M in Common Stock Sold Through ATM Program
May 26, 2017 06:30AM
May 25, 2017 04:03PM
May 25, 2017 04:02PM
May 24, 2017 04:12PM
May 24, 2017 04:01PM
May 15, 2017 06:32AM
May 15, 2017 06:30AM Aerie Pharmaceuticals Announces FDA Acceptance of NDA Submission for Rhopressa™ (netarsudil ophthalmic solution) 0.02%
Aug 2, 2016 02:21PM

15,404 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All